Case File
efta-efta00630949DOJ Data Set 9OtherFrom: Tazia Smith
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00630949
Pages
2
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Tazia Smith
To: "Jeffrey epstein" <jeevacation®gmail.com>
Cc: "Paul Morria,
"Rich Kahn"
Stepanian"
Subject: Re: Alibaba [C]
Date: Tue, 16 Sep 2014 12:26:44 +0000
Importance: Normal
>, >, "Vahe
Classification: Confidential
Thank you
Tazia Smith
Director
Key Client Partners - US
Deutsche Bank Securities, Inc.
Deutsche Asset & Wealth Management
345 Park Avenue - 26th Floor
New York. NY 10154
From: "jeffrey E." [[email protected]]
Sent: 09/16/2014 06:08 AM AST
To: Tazia Smith
Subject: Re: Alibaba [C]
Yes
On Tue, Sep 16, 2014 at 2:02 AM, Tazia Smith <
> wrote:
Classification: Confidential
Good Morning Jeffrey - Please confirm or modify your indication of interest of 250k shares of Alibaba. As you
know, scheduled pricing is Thursday for trading Friday.
Thanks,
Tazia
Tazia Smith
Director
Key Client Partners - US
Deutsche Bank Securities, Inc.
EFTA00630949
Deutsche Asset & Wealth Management
345 Park Avenue - 26th Floor
This communication may contain confidential and/or privileged information.
If you are not the intended recipient (or have received this communication
in error) please notify the sender immediately and destroy this
communication. Any unauthorized copying, disclosure or distribution of the
material in this communication is strictly forbidden.
Deutsche Bank does not render legal or tax advice, and the information
contained in this communication should not be regarded as such.
please note
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
JEE
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to
and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
This communication may contain confidential and/or privileged information.
If you are not the intended recipient (or have received this communication
in error) please notify the sender immediately and destroy this
communication. Any unauthorized copying, disclosure or distribution of the
material in this communication is strictly forbidden.
Deutsche Bank does not render legal or tax advice, and the information
contained in this communication should not be regarded as such.
EFTA00630950
Technical Artifacts (1)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.